z-logo
open-access-imgOpen Access
Fetal Valproate Syndrome – A Case Report
Publication year - 2018
Publication title -
advances in neurology and neuroscience
Language(s) - English
Resource type - Journals
ISSN - 2690-909X
DOI - 10.33140/an.01.01.03
Subject(s) - valproic acid , medicine , pregnancy , in utero , fetus , autism spectrum disorder , facial dysmorphism , epilepsy , pediatrics , autism , psychiatry , chemistry , biology , biochemistry , genetics , gene , phenotype
Background: Fetal Valproate Syndrome (FVS) results from prenatal exposure to valproic acid (VPA).Case characteristics: A four year old female child presented with facial dysmorphism and features of autism spectrumdisorder (ASD). She had in-utero exposure to valproic acid (VPA).Message: VPA to be avoided in pregnancy and in Dysmorphism or ASD children maternal anti- convulsant drug historymust be taken.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here